View Rule

View EO 12866 Meetings

Printer-Friendly Version     Download RIN Data in XML

---

DOJ/DEA

RIN: 1117-AB31

Publication ID: Fall 2011

Title: Classification of Two Steroids, Prostanozol and Methasterone, as Schedule III Anabolic Steroids Under the Controlled Substances Act
Abstract: This rule proposes to classify the following two steroids as "anabolic steroids" under the Controlled Substances Act (CSA): prostanozol and methasterone. The Drug Enforcement Administration (DEA) believes that this action is necessary to prevent the abuse and trafficking of these steroids. If the regulations are amended, these steroids will be listed as Schedule III controlled substances subject to the regulatory control provisions of the CSA.
Agency: Department of Justice(DOJ)	Priority: Substantive, Nonsignificant
RIN Status: Previously published in the Unified Agenda	Agenda Stage of Rulemaking: Proposed Rule Stage
Major: No	Unfunded Mandates: No
CFR Citation: 21 CFR 1300
Legal Authority: 21 USC 802    21 USC 821    21 USC 829    21 USC 871    21 USC 951    21 USC 958

Legal Deadline:  None

Timetable: Action Date FR Cite NPRM  12/00/2011

Additional Information: Docket Number DEA-341
Regulatory Flexibility Analysis Required: No	Government Levels Affected: None
Federalism: No
Included in the Regulatory Plan: No
RIN Data Printed in the FR: No
Agency Contact: Demetra Ashley Associate Deputy Assistant Administrator Department of Justice Drug Enforcement Administration 8701 Morrissette Drive, Springfield, VA 22152 Phone:202 307-7165